Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...
One of the top worries about telehealth is that it will drive up the use of tests and scans that patients don't need, wasting money and resources. In fact, a new study shows, low-value care didn't ...